Stock Events

Stock Events

Royalty Pharma

€42.13

371

+€0.12+0.27% Monday 06:03

Statistics

Day High

42.13

Day Low

42.13

52W High

42.13

52W Low

27.93

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

1.91%

Dividend

0.8

Upcoming

Dividend Payment

Dividend Payment

Dividends

1.91%Dividend Yield

Mar 26

€0.2

Dec 25

€0.19

Sep 25

€0.19

Jun 25

€0.2

Mar 25

€0.21

10Y Growth

N/A

5Y Growth

6.88%

3Y Growth

2.7%

1Y Growth

2.31%

Earnings

12AugExpected

Q4 2025

Q1 2026

Next

0.45

0.71

0.97

1.23

Expected EPS

1.0229372582499998

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RPD.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company that competes with Royalty Pharma in the acquisition and management of pharmaceutical royalties, particularly through its string of acquisitions that expand its portfolio in similar therapeutic areas.

Pfizer is a large pharmaceutical company that competes with Royalty Pharma in the development and commercialization of medical treatments, and it also engages in deals and partnerships that involve royalty agreements.

Gilead Sciences

Gilead Sciences is involved in the research, development, and commercialization of drugs in areas like HIV/AIDS, liver diseases, and oncology, competing with Royalty Pharma in acquiring royalties in these therapeutic areas.

AbbVie operates in the pharmaceutical industry, focusing on acquiring and developing a portfolio of medicines, directly competing with Royalty Pharma in the market for drug royalties and investments in pharmaceutical innovations.

Merck & Co. is a global healthcare company that competes with Royalty Pharma through its extensive drug development programs and partnerships that may involve royalty financing and agreements.

Johnson & Johnson

Johnson & Johnson is a diversified healthcare giant that competes across various segments, including pharmaceuticals. Its involvement in drug development and royalty agreements places it in competition with Royalty Pharma.

AstraZeneca is a multinational pharmaceutical and biopharmaceutical company, competing with Royalty Pharma in the acquisition of drug royalties and through its focus on innovative drug development.

Sanofi is a global healthcare leader that competes with Royalty Pharma in the pharmaceutical sector, particularly through its efforts to secure drug royalties and its focus on innovative treatments.

Novartis is a global healthcare company that competes with Royalty Pharma through its significant investments in drug development and its strategy to acquire and manage drug royalties.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Royalty Pharma in the market for pharmaceutical royalties, especially in the generic sector where royalties are a key component of profitability.

About

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Show more...

CEO

Mr. Pablo Legorreta

Employees

100

Country

United Kingdom

ISIN

GB00BMVP7Y09

Listings

0 Comments

Share your thoughts

FAQ

What is Royalty Pharma stock price today?▼

The current price of RPD.MU is €42.13 EUR — it has increased by +0.27% in the past 24 hours. Watch Royalty Pharma stock price performance more closely on the chart.

What is Royalty Pharma stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Royalty Pharma stocks are traded under the ticker RPD.MU.

Is Royalty Pharma stock price growing?▼

RPD.MU stock has risen by +0.27% compared to the previous week, the month change is a +2.32% rise, over the last year Royalty Pharma has showed a +46.22% increase.

When is the next Royalty Pharma earnings date?▼

Royalty Pharma is going to release the next earnings report on August 12, 2026.

What were Royalty Pharma earnings last quarter?▼

RPD.MU earnings for the last quarter are 0.45 EUR per share, whereas the estimation was 0.94 EUR resulting in a -52.07% surprise. The estimated earnings for the next quarter are N/A EUR per share.

Does Royalty Pharma pay dividends?▼

Yes, RPD.MU dividends are paid quarterly. The last dividend per share was 0.2 EUR. As of today, Dividend Yield (FWD)% is 1.91%.

How many employees does Royalty Pharma have?▼

As of May 06, 2026, the company has 100 employees.

In which sector is Royalty Pharma located?▼

Royalty Pharma operates in the Health & Wellness sector.

When did Royalty Pharma complete a stock split?▼

Royalty Pharma has not had any recent stock splits.

Where is Royalty Pharma headquartered?▼

Royalty Pharma is headquartered in New York, United Kingdom.